A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
Adam Leach, F. Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma Bentley, Giada Mattiuzzo, Shimobi Onuoha, Ami Miller, Hanif Ali, Terence H. Rabbitts
Topics & Concepts
DecoyPotencyNeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirusAngiotensin-converting enzyme 2PandemicSpike ProteinCoronavirus disease 2019 (COVID-19)Plasma protein bindingChemistryViral entryBiologyVirusReceptorBiochemistryMedicineIn vitroViral replicationDiseasePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing